Impact of participant and interventionist race concordance on weight loss outcomes

Obesity

Volumn 21, Issue 4, 2013, Pages 712-717

  Batch, Bryan C ^a   Ard, Jamy D ^b,c   Vollmer, William M ^d   Funk, Kristine ^d   Appel, Lawrence J ^e   Stevens, Victor J ^d   Samuel Hodge, Carmen ^f   Loria, Catherine M ^g   Hollis, Jack F ^d   Svetkey, Laura P ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c University of Alabama at Birmingham   (United States)

^d CENTER FOR HEALTH RESEARCH   (United States)

^e JOHNS HOPKINS UNIVERSITY   (United States)

^f University of North Carolina   (United States)

^g NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AFRICAN AMERICAN; ARTICLE; BEHAVIOR CHANGE; CONTROLLED STUDY; DYSLIPIDEMIA; FEMALE; GROUP THERAPY; HUMAN; HYPERTENSION; LOW CALORY DIET; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY (TOPIC); OBESITY; PHYSICAL ACTIVITY; POST HOC ANALYSIS; RACE DIFFERENCE; WEIGHT CHANGE; WEIGHT REDUCTION;

EID: 85027930213     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1002/oby.20270     Document Type: Article

References (36)

1. Flegal KM, Carroll MD, Ogden CL, Curtin LR,. Prevalence and trends in obesity among US adults, 1999-2008. JAMA 2010; 303: 235-241.
2. Poirier P, Giles TD, Bray GA, et al,. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 2006; 113: 898-918.
3. Centers for Disease Control and Prevention. National Diabetes Fact Sheet: General Information and National Estimates on Diabetes in the United States, 2007. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention: Atlanta, GA, 2008.
4. Lloyd-Jones D, Adams R, Brown TM, et al,. Heart disease and stroke statistics-2010 update. A report from the American Heart Association. Circulation 2010; 121: e1-e170.
5. Knowler WC, Barrett-Connor E, Fowler SE, et al,.; Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346: 393-403.
6. Stevens VJ, Corrigan SA, Obarzanek E, et al,. Weight loss intervention in phase 1 of the Trials of Hypertension Prevention. The TOHP Collaborative Research Group. Arch Intern Med 1993; 153: 849-858.
7. Hollis JF, Gullion CM, Stevens VJ, et al,.; Weight Loss Maintenance Trial Research Group. Weight loss during the intensive intervention phase of the weight-loss maintenance trial. Am J Prev Med 2008; 35: 118-126.
8. Appel LJ, Champagne CM, Harsha DW, et al,.; Writing Group of the PREMIER Collaborative Research Group. Effects of comprehensive lifestyle modification on blood pressure control: main results of the PREMIER clinical trial. JAMA 2003; 289: 2083-2093.
9. Whelton PK, Appel LJ, Espeland MA, et al,. Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). TONE Collaborative Research Group. JAMA 1998; 279: 839-846.
10. Kumanyika SK, Obarzanek E, Stevens VJ, et al,. Weight-loss experience of black and white participants in NHLBI-sponsored clinical trials. Am J Clin Nutr 1991; 53: 1631S-1638S.
11. Wing RR, Anglin K,. Effectiveness of a behavioral weight control program for blacks and whites with NIDDM. Diabetes Care 1996; 19: 409-413.
12. Kumanyika SK, Espeland MA, Bahnson JL, et al,.; TONE Cooperative Research Group. Ethnic comparison of weight loss in the Trial of Nonpharmacologic Interventions in the Elderly. Obes Res 2002; 10: 96-106.
13. Cooper-Patrick L, Gallo JJ, Gonzales JJ, et al,. Race, gender, and partnership in the patient-physician relationship. JAMA 1999; 282: 583-589.
14. Cooper LA, Roter DL, Johnson RL, et al,. Patient-centered communication, ratings of care, and concordance of patient and physician race. Ann Intern Med 2003; 139: 907-915.
15. Schnittker J, Liang K,. The promise and limits of racial/ethnic concordance in physician-patient interaction. J Health Polit Policy Law 2006; 31: 811-838.
16. Traylor AH, Schmittdiel JA, Uratsu CS, Mangione CM, Subramanian U,. Adherence to cardiovascular disease medications: does patient-provider race/ethnicity and language concordance matter ? J Gen Intern Med 2010; 25: 1172-1177.
17. Brantley P, Appel L, Hollis J, et al,. Design considerations and rationale of a multi-center trial to sustain weight loss: the Weight Loss Maintenance Trial. Clin Trials 2008; 5: 546-556.
18. Block G, Subar AF,. Estimates of nutrient intake from a food frequency questionnaire: the 1987 National Health Interview Survey. J Am Diet Assoc 1992; 92: 969-977.
19. Chen C, Jerome GJ, Laferriere D, Young D, Vollmer WM,. Procedures used to standardize data collected by RT3 triaxial accelerometers in a large scale weight-loss trial. J Phys Act Health 2009; 6: 354-359.
20. Jerome GJ, Young DR, Laferriere D, Chen C, Vollmer WM,. Reliability of RT3 accelerometers among overweight and obese adults. Med Sci Sports Exerc 2009; 41: 110-114.
21. Appel LJ, Moore TJ, Obarzanek E, et al,. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med 1997; 336: 1117-1124.
22. Sacks FM, Svetkey LP, Vollmer WM, et al,.; DASH-Sodium Collaborative Research Group. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med 2001; 344: 3-10.
23. Harsha DW, Sacks FM, Obarzanek E, et al,. Effect of dietary sodium intake on blood lipids: results from the DASH-sodium trial. Hypertension 2004; 43: 393-398.
24. Appel LJ, Sacks FM, Carey VJ, et al,.; OmniHeart Collaborative Research Group. Effects of protein, monounsaturated fat, and carbohydrate intake on blood pressure and serum lipids: results of the OmniHeart randomized trial. JAMA 2005; 294: 2455-2464.
25. Bandura A,. Social Foundations of Thought and Action: A Social Cognitive Theory. Prentice Hal: Englewood Cliffs, NJ; 1986.
26. Prochaska JM, Prochaska JO, Levesque DA,. A transtheoretical approach to changing organizations. Adm Policy Ment Health 2001; 28: 247-261.
27. Little RJA, Rubin DB,. Statistical Analysis with Missing Data, 2nd ed, Wiley: Hoboken, NJ; 2002.
28. Collins LM, Schafer JL, Kam CM,. A comparison of inclusive and restrictive strategies in modern missing data procedures. Psychol Methods 2001; 6: 330-351.
29. Street RL Jr, O'Malley KJ, Cooper LA, Haidet P,. Understanding concordance in patient-physician relationships: personal and ethnic dimensions of shared identity. Ann Fam Med 2008; 6: 198-205.
30. Institute of Medicine. Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care. National Academy Press: Washington, DC; 2002.
31. LaVeist TA, Nuru-Jeter A, Jones KE,. The association of doctor-patient race concordance with health services utilization. J Public Health Policy 2003; 24: 312-323.
32. Boulware LE, Cooper LA, Ratner LE, LaVeist TA, Powe NR,. Race and trust in the health care system. Public Health Rep 2003; 118: 358-365.
33. Traylor AH, Subramanian U, Uratsu CS, et al,. Patient race/ethnicity and patient-physician race/ethnicity concordance in the management of cardiovascular disease risk factors for patients with diabetes. Diabetes Care 2010; 33: 520-525.
34. Bleich SN, Simon AE, Cooper LA,. Impact of patient-doctor race concordance on rates of weight related counseling in visits by black and white obese individuals. Obesity 2012; 20: 562-570.
35. Kumanyika SK, Wadden TA, Shults J, et al,. Trial of family and friend support for weight loss in African American adults. Arch Intern Med 2009; 169: 1795-1804.
36. Ard JD, Kumanyika S, Stevens VJ, et al,. Effect of group racial composition on weight loss in African Americans. Obesity (Silver Spring) 2008; 16: 306-310.